Medtronic, Inc. (MDT) Tops Q2 EPS by 2c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $94.17 +1.15%
Revenue Growth %: +5.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.3%
Financial Fact:
Amortization Of Intangible Assets: 89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q2 EPS of $0.84, $0.02 better than the analyst estimate of $0.82. Revenue for the quarter came in at $4.13 billion versus the consensus estimate of $4.07 billion.
Medtronic, Inc. reaffirmed FY2011 guidance.
Medtronic, Inc. reaffirmed FY2011 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic, Inc. (MDT) PT Raised to $105 at Bernstein SocGen Group
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
